Bizarre Patents
Cloaking System Using Optoelectronically Controlled Camouflage
A Cloaking System designed to operate in the visible light spectrum, utilizes optoelectronics and/or photonic components to conceal an object within it.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120129833 | CYCLIC KETOENOLS FOR THERAPY The invention relates to 5′-biphenyl-substituted cyclic ketoenols for therapeutic purposes, to pharmaceutical compositions and to their use in therapy, in particular for the prophylaxis and therapy of diabetes, obesity, hyperlipidaemia, fatty livers and of disorders o... | 05/24/2012 |
| 20120129894 | Alkoxy Compounds for Disease Treatment The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are alkoxyl derivative compounds and pharmaceutical compositions comprising these c... | 05/24/2012 |
| 20120107229 | NOVEL NANO-PROBES FOR MOLECULAR IMAGING AND TARGETED THERAPY OF DISEASES The present inventions relate to compositions and methods for imaging and treating atherosclerotic diseases, pathogen infections, and tumors by administering actively targeting magnetic nanoparticles. In particular, the present inventions provide new types of targeting ... | 05/03/2012 |
| 20120053208 | Curcumin Analogs as Dual JAK2/STAT3 Inhibitors and Methods of Making and Using the Same Curcumin analogues and methods of making and using the same are disclosed.... | 03/01/2012 |
| 20120015807 | Trifluromethoxyphenyl-Substituted Tetramic Acid Derivatives Pesticides and/or Herbicides The present invention relates to novel trifluoromethoxyphenyl-substituted tetramic acid derivatives of the formula (I), in which | 01/19/2012 |
| 20110281930 | Use of 2-Aryl-5-heterocyclyl-cyclohexane-1,3-dione Compounds as Insecticides, Acaricides, and/ or Fungicides The present invention relates to the use of compounds of Formula (I) wherein R1, R2, R3, R4, R5, R6, R7, R8, X and G have the meanings given above as insecticides and/or acaricides a... | 11/17/2011 |
| 20110269713 | BRYOSTATIN ANALOGUES AND METHODS OF MAKING AND USING THEREOF Described herein are tricyclic macrolactones. The macrolactones have a high binding affinity for PKC. The compounds described herein can be used in a number of therapeutic applications including cancer and Alzheimer's prevention and treatment. The compounds described he... | 11/03/2011 |
| 20110257255 | COMPOSITION AND METHOD FOR INHIBITION OF NERVE TRANSMISSION The presently claimed and disclosed invention(s) provides a therapeutically effective composition and method of inhibiting nerve cell transmission. In a preferred embodiment of the presently claimed and disclosed invention(s), the treatment of neuropathic pain utilizing... | 10/20/2011 |
| 20110237592 | SUBSTITUTED AMIDO PHENOXYBENZAMIDES The present invention relates to substituted amido phenoxybenzamide compounds of general formula (I): in which A, R1, R2, R3, R4, R5, R6, R7, R8, R9 and n are as defined in the claims, to pharmaceutical compo... | 09/29/2011 |
| 20110206764 | FORMULATIONS FOR ENHANCED BIOAVAILABILITY OF ORALLY ADMINISTERED POLAR AGENTS A composition is described having improved oral permeability of polar agents such as neuraminidase inhibitors. The composition includes one or more polar agents and one or more permeability enhancers such that the composition increases the amount of the polar agent capa... | 08/25/2011 |
| 20110144191 | COMPOSITIONS COMPRISING TERPENE COMPOUNDS FOR TREATING NEGATIVE SENSORY PHENOMENA Compositions comprising terpene compounds for the treatment of negative sensory phenomena (NSP). Negative sensory phenomena is characterized by a decreased ability to sense light touch, pin prick, vibration, temperature, pain and/or reduced proprioception. The terpene c... | 06/16/2011 |
| 20110086908 | USE OF PHOSPHATASE INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES Provided are novel a target and drugs in the treatment of neurological disorders related to amyloid beta pathology/amyloidosis. More specifically, the use of phosphatase inhibitors for the treatment of brain impairments mediated by Aβ-oligomers is described.... | 04/14/2011 |
| 20110046212 | USE OF OLEUROPEIN AND DERIVATIVES IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS AND PATHOLOGIES ASSOCIATED WITH PROTEIN AGGREGATION PHENOMENA This invention relates to the use of oleuropein, specifically oleuropein in non-glycated form, and its derivatives in the treatment of type 2 diabetes mellitus. Furthermore, this invention relates to the use of oleuropein, specifically oleuropein in non-glycated form, a... | 02/24/2011 |
| 20100261772 | Cycloalkylidene Compounds As Selective Estrogen Receptor Modulators The present invention relates to compounds of formula (I) with a variety of therapeutic uses, more particularly the substituted cyclic alkylidene compounds are useful for selective estrogen receptor modulation. ... | 10/14/2010 |
| 20100256156 | HETEROCYCLIC COMPOUND The present invention provides a heterocyclic compound represented by the following formula (I), which has a glucagon antagonistic action and is useful for the prophylaxis or treatment of diabetes and the like, a compound represented by | 10/07/2010 |
| 20100226864 | ALKYL-SUBSTITUTED TETRAHYDROPYRANS AS FLAVORING SUBSTANCES The present invention relates to alkyl-substituted tetrahydropyrans, mixtures containing these alkyl-substituted tetrahydropyrans, their respective use and corresponding flavored products.... | 09/09/2010 |
| 20100197684 | SUBSTITUTED HETEROCYCLIC COMPOUNDS The present invention relates to novel heterocyclic compounds and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes. In particular embodiments, the structure of the compounds is given by Formula (I): 08/05/2010 | |
| 20100076068 | Aminoalcohol Derivatives and Their Therapeutic Use A compound of formula (1) Including pharmaceutically acceptable salts thereof, wherein: R1 is aryl or heteroaryl optionally substituted with R8; R2 is H or alkyl or CH2 (when forming part of a ring with R3, R4 ... | 03/25/2010 |
| 20100062065 | PHARMACEUTICAL COMPOSITION CONTAINING NAPHTHOQUINONE-BASED COMPOUND FOR INTESTINE DELIVERY SYSTEM Provided is an oral pharmaceutical composition with improved bioavailability and pharmacokinetic properties of a drug, by increasing a bioabsorption rate and an in vivo retention time of an active ingredient via intestine-targeted formulation of a particular naphthoquin... | 03/11/2010 |
| 20100048572 | NAPHTHALENONE COMPOUNDS EXHIBITING PROLYL HYDROXYLASE INHIBITORY ACTIVITY, COMPOSITIONS, AND USES THEREOF Compounds of Formula I and Formula II are useful as inhibitors of HIF prolyl hydroxylases. Compounds of Formula I and Formula II have the following structures: where the definitions of the variables are provi... | 02/25/2010 |
| 20100048687 | USE OF PHOSPHATASE INHIBITORS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES Provided are novel a target and drugs in the treatment of neurological disorders related to amyloid beta pathology/amyloidosis. More specifically, the use of phosphatase inhibitors for the treatment of brain impairments mediated by Aβ-oligomers is described.... | 02/25/2010 |
| 20100028460 | IMPROVEMENTS IN RELATION TO CANCER THERAPY The present invention relates to an improved assay for identifying compounds that may be of use in conjunction with cancer chemotherapeutic agents and anti-proliferative agents, to improve efficacy of such agents and/or render effective compounds with relatively little ... | 02/04/2010 |
| 20090269427 | HERBAL COMPOSITION FOR INFLAMMATORY DISORDERS This invention relates to a novel herbal composition comprising an extract of flowering and fruiting heads of the plant, Sphaeranthus indicus. The said extract of Sphaeranthus indicus contains a compound, 3a-hydroxy-5a,9-dimethyl-3-methylene-3a,4,5,5a,6,7,... | 10/29/2009 |
| 20090270494 | Salts of Dihydroxyanthraquinone Carboxylic Acids and Their Therapeutic Use A compound of general formula (I): wherein Xi is H or COR1 and X2 is H or COR2 but X1 and X2 are not both H; R1 and R2 are the same or different and are each C1-4 alkyl substituted w... | 10/29/2009 |
| 20090099253 | Internally Masked Neopentyl Sulfonyl Ester Cyclization Release Prodrugs of Acamprosate, Compositions Thereof, and Methods of Use Internally masked neopentyl sulfonyl ester prodrugs of acamprosate, pharmaceutical compositions comprising such prodrugs, and methods of using such prodrugs and compositions thereof for treating diseases are disclosed. In particular, acamprosate prodrugs exhibiting enha... | 04/16/2009 |
| 20080234258 | Dihydroxyanthraquinones and Their Use A compound of formula (1) wherein X is H or —OCR1 and Y is H or —OCR2, provided that X and Y are not both H; and R is CH2OR9, CONR11R12, C... | 09/25/2008 |
| 20080226716 | AMINO ACID CONJUGATES PROVIDING FOR SUSTAINED SYSTEMIC CONCENTRATION OF GABA ANALOGUES Compounds that provide for sustained systemic concentrations of GABA analogs following oral administration to animals are disclosed. Pharmaceutical compositions including, and methods using, such compounds are also disclosed.... | 09/18/2008 |
| 20080194673 | Environment-Friendly Pollution-Proof Agent The present invention relates to an environmental friendly antifouling agent, and more particularly, to a novel Sargassum-derived antifouling agent which is harmless to environment, has antifouling activity against a broad spectrum of fouling organisms, can be ex... | 08/14/2008 |
| 20080188548 | Cyclic ether vitamin D3 compounds, 1alpha(OH)3-epi-vitamin D3 compounds and uses thereof Novel cyclic ether vitamin D3 compounds having a cyclic ether side chain are disclosed. These compounds were first identified as metabolites of 3-epi vitamin D3 produced via a tissue-specific metabolic pathway which catalyzes the formation of a cyclic ether structure. A... | 08/07/2008 |
| 20080138297 | Pyran derivatives, process of preparation and use thereof in perfumery and flavouring Pyran derivatives of general formula (I) wherein
| 06/12/2008 |
| 20080085893 | MATRIX METALLOPROTEASE INHIBITORS The present invention relates to compounds of Formula I, wherein R1, R2, R3, R4, R5, R6, and R7 are defined in the specification. In addition, the present invention relates to methods treating disorders related to matrix metalloproteases. More particularly, the comp... | 04/10/2008 |
| 20080039506 | Aminoalcohol Derivatives The present invention relates to a compound of the formula [I]: wherein (a), in which —Y—, R4, R5 and R6 are4 R5 each as defined in the description, etc., R1 is hydrogen, halogen, lower alkyl, hydroxy... | 02/14/2008 |
| 20080027096 | Novel Pharmaceutical Compositions The invention provides compounds of formula (I) or a pharmaceutically acceptable ester, amide, solvate or salt thereof, including a salt of such an ester or amide, and a solvate of such an ester, amide or salt, for use in the treatment or prophylaxis of condition mediat... | 01/31/2008 |
| 20070287745 | Laulimalide Analogs and Uses Thereof The present invention provides compounds having formula I:
| 12/13/2007 |
| 20070270452 | Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders Novobiocin analogues and pharmaceutical composition containing such compounds useful for the treatment and/or prevention of neurodegenerative disorders and autoimmune disorders. ... | 11/22/2007 |
| 20070249565 | Class of Gamma Delta T Cells Activators and Use Thereof The present invention relates to a new class of compounds having γδ T cells activating properties of Formula (I), a composition comprising these compounds and methods for regulating an immune response in a subject comprising the step of administering these compoun... | 10/25/2007 |
| 20070244187 | Intermediates for the Preparation of Halichondrin B The present invention provides macrocyclic compounds, synthesis of the same and intermediates thereto. Such compounds, and compositions thereof, are useful for treating or preventing proliferative disorders Formula (F-4). ... | 10/18/2007 |
| 20070238769 | Bone Densifying Agent Characterized By Use Of Cathepsin K Inhibitor With Pth The present invention relates to an agent for increasing BMD characterized by use of a cathepsin K inhibitor as a bone resorption inhibitor in combination with a type of PTH as a bone formation stimulator. This agent for increasing BMD is useful for the treatment of os... | 10/11/2007 |
| 20070232686 | Cyanoamidine P2X7 Antagonists for the Treatment of Pain Novel cyanoamidines compounds of formula (I) and (II) and their derivatives wherein R1-R12 are as defined in the specification act as antagonists of the P2X7 receptor. These compounds are particularly u... | 10/04/2007 |
| 20070225357 | Formulation for Stimulating Hair Growth The present invention is directed to a topical formulation comprising the Compound 6-[[(3S,4R)-3,4-dihydro-3-hydroxy-6-[(3-hydroxyphenyl)sulfonyl)-2,2,3-trimethyl-2H-1-benzopyran-4-yl]oxy]-2-methyl-3(2H)-pyridazinone in a formulation comprising at least one pharmaceutic... | 09/27/2007 |
